Jin Medical International Ltd. (ZJYL)

NASDAQ: ZJYL · IEX Real-Time Price · USD

2.570

-0.030 (-1.15%)

At close: Jul 2, 2024, 3:59 PM

2.597

+0.027 (1.05%)

After-hours: Jul 2, 2024, 7:49 PM EDT

Jin Medical International Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021
Revenue	19.82	19.19	20.76
Revenue Growth (YoY)	3.29%	-7.58%	-
Cost of Revenue	13.04	12.99	14.4
Gross Profit	6.78	6.2	6.36
Selling, General & Admin	2.37	2.18	2.16
Research & Development	1.54	1.89	1.57
Operating Expenses	3.92	4.07	3.73
Operating Income	2.87	2.13	2.63
Interest Expense / Income	-0.18	-0.18	0.01
Other Expense / Income	-0.17	-0.43	-0.26
Pretax Income	3.22	2.74	2.88
Income Tax	0.34	0.04	0.25
Net Income	2.88	2.71	2.63
Net Income Growth	6.34%	2.84%	-
Shares Outstanding (Basic)	145	135	135
Shares Outstanding (Diluted)	145	135	135
Shares Change	7.51%	-	-
EPS (Basic)	0.02	0.02	0.02
EPS (Diluted)	0.02	0.02	0.02
Free Cash Flow	3	1.54	5.8
Free Cash Flow Per Share	0.02	0.01	0.04
Gross Margin	34.23%	32.30%	30.64%
Operating Margin	14.47%	11.10%	12.67%
Profit Margin	14.52%	14.10%	12.67%
Free Cash Flow Margin	15.15%	8.03%	27.93%
Effective Tax Rate	10.67%	1.32%	8.63%
EBITDA	3.27	2.92	3.24
EBITDA Margin	16.47%	15.23%	15.59%
Depreciation & Amortization	0.23	0.36	0.35
EBIT	3.04	2.56	2.89
EBIT Margin	15.33%	13.35%	13.92%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).